Larimar Therapeutics, Inc. (NASDAQ:LRMR) Given Consensus Recommendation of “Buy” by Brokerages
Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) have earned a consensus recommendation of “Buy” from the eleven brokerages that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, seven have assigned a buy rating and three have issued a strong buy rating on [...]
